Parmax Pharma Ltd
company logo

Parmax Pharma Ltd

Parmax Pharma Share Price

Pharmaceuticals
Small Cap

-

0 (0%)

Start Investing in Parmax Pharma Ltd

*By signing up you agree to our Terms and Conditions

Parmax Pharma Ltd Performance

-

-

-

-


-

-

-

-

-

Parmax Pharma Ltd Fundamentals

13.39Cr

0

0

1.91

0

0%

-1.71

i buttonClick here to know more about Fundamentals

Parmax Pharma Ltd Financials

Parmax Pharma Ltd Financialsright-arrow

Parmax Pharma Ltd Shareholding Pattern

Parmax Pharma Ltd Delivery and Volume

About Parmax Pharma Ltd

Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Pr

Umang Alkesh Gosalia

1994

-

NameDesignation
Umang Alkesh GosaliaManaging Director
Ami R ShahNon-Exec. & Independent Dir.
Yash VoraCompany Sec. & Compli. Officer
Nikhil S. UchatIndependent Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Parmax Pharma Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Parmax Pharma Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Parmax Pharma Ltd's share price is ₹35.79 as of 2024-10-10.
Parmax Pharma Ltd's P/E ratio is - times as of 2024-10-10.
Parmax Pharma Ltd's most recent financial reports indicate a price-to-book ratio of -, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Parmax Pharma Ltd's market capitalization is ₹13.39 Cr as on 2024-10-10.
The current financial records of Parmax Pharma Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Parmax Pharma Ltd's most recent financial filings, the company has a total asset value of ₹5.77, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Parmax Pharma Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Parmax Pharma Ltd's 52-week high and low as of 2024-10-10 are ₹35.79 and ₹35.79, respectively.